Intestinal Research

Animal models of inflammatory bowel disease: novel experiments for revealing pathogenesis of colitis, fibrosis, and colitis-associated colon cancer: Chan Hyung Lee, Seong-Joon Koh, Zaher A Radi, Aida Habtezion; Received March 14, 2023 Accepted April 3, 2023; DOI: https://doi.org/10.5217/ir.2023.00029 [Epub ahead of print]; PDF

Comparative outcomes of acute colonic diverticulitis in immunocompromised versus immunocompetent patients: a systematic review and meta-analysis: Jae Gon Lee, Yong Eun Park, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Shin Hee Lee, Myung-Won You, Seong-Eun Kim; Received January 9, 2023 Accepted March 31, 2023; DOI: https://doi.org/10.5217/ir.2023.00005 [Epub ahead of print]; PDF

Clinical characteristics and risk factors related to polyposis recurrence and advanced neoplasm development among patients with non-hereditary colorectal polyposis: Jihun Jang, Jihye Park, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Tae Il Kim; Received December 28, 2022 Accepted April 12, 2023; DOI: https://doi.org/10.5217/ir.2022.00139 [Epub ahead of print]; PDF

Artificial intelligence in inflammatory bowel disease: implications for clinical practice and future directions: Harris A. Ahmad, James E. East, Remo Panaccione, Simon Travis, James B. Canavan, Keith Usiskin, Michael F. Byrne; Received February 8, 2023 Accepted March 11, 2023; DOI: https://doi.org/10.5217/ir.2023.00020 [Epub ahead of print]; PDF

Does caffeine have a double-edged sword role in inflammation and carcinogenesis in the colon?: Emiko Mizoguchi, Takayuki Sadanaga, Toshiyuki Okada, Takanori Minagawa, Jun Akiba; Received October 21, 2022 Accepted March 6, 2023; DOI: https://doi.org/10.5217/ir.2022.00118 [Epub ahead of print]; PDF

Serum albumin is the strongest predictor of anti-tumor necrosis factor nonresponse in inflammatory bowel disease in resource-constrained regions lacking therapeutic drug monitoring: Peeyush Kumar, Sudheer K. Vuyyuru, Prasenjit Das, Bhaskar Kante, Mukesh Kumar Ranjan, David Mathew Thomas, Sandeep Mundhra, Pabitra Sahu, Pratap Mouli Venigalla, Saransh Jain, Sandeep Goyal, Rithvik Golla, Shubi Virmani, Mukesh K. Singh, Karan Sachdeva, Raju Sharma, Nihar Ranjan Dash, Govind Makharia, Saurabh Kedia, Vineet Ahuja; Received November 15, 2022 Accepted January 9, 2023; DOI: https://doi.org/10.5217/ir.2022.00128 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Submucosal fat accumulation in Crohn’s disease: evaluation with sonography: Tomás Ripollés, María Jesús Martínez-Pérez, José María Paredes, José Vizuete, Gregorio Martin, Lidia Navarro; Received June 17, 2022 Accepted December 23, 2022; DOI: https://doi.org/10.5217/ir.2022.00030 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF

Clinical features of enteric and colo-duodenal fistula in patients with Crohn’s disease: Jun Su Lee, Sang-Bum Kang, Kwangbeom Park, Yong Sik Yoon, Chang Sik Yu, Sung Wook Hwang, Byong Duk Ye, Suk-Kyun Yang, Jong Lyul Lee, Sang Hyoung Park; Received November 8, 2022 Accepted January 22, 2023; DOI: https://doi.org/10.5217/ir.2022.00125 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Risk of venous thromboembolism with a central venous catheter in hospitalized Japanese patients with inflammatory bowel disease: a propensity score-matched cohort study: Yasuhiro Aoki, Hiroki Kiyohara, Yohei Mikami, Kosaku Nanki, Takaaki Kawaguchi, Yusuke Yoshimatsu, Shinya Sugimoto, Tomohisa Sujino, Kaoru Takabayashi, Naoki Hosoe, Haruhiko Ogata, Yasushi Iwao, Takanori Kanai; Received September 23, 2022 Accepted December 4, 2022; DOI: https://doi.org/10.5217/ir.2022.00116 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Prevalence of hepatitis B virus and hepatitis C virus infection in patients with inflammatory bowel disease: a systematic review and meta-analysis: Suprabhat Giri, Dhiraj Agrawal, Shivaraj Afzalpurkar, Sunil Kasturi, Amrit Gopan, Sridhar Sundaram, Aditya Kale; Received July 19, 2022 Accepted August 30, 2022; DOI: https://doi.org/10.5217/ir.2022.00094 [Epub ahead of print]
Cited By 1; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Low prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease in India: Arshdeep Singh, Vandana Midha, Vikram Narang, Saurabh Kedia, Ramit Mahajan, Pavan Dhoble, Bhavjeet Kaur Kahlon, Ashvin Singh Dhaliwal, Ashish Tripathi, Shivam Kalra, Narender Pal Jain, Namita Bansal, Rupa Banerjee, Devendra Desai, Usha Dutta, Vineet Ahuja, Ajit Sood; Received July 9, 2022 Accepted September 19, 2022; DOI: https://doi.org/10.5217/ir.2022.00087 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF

Inflammatory bowel disease (IBD)-disk accurately predicts the daily life burden and parallels disease activity in patients with IBD: Arshdeep Singh, Yogesh Kumar Gupta, Ashvin Singh Dhaliwal, Bhavjeet Kaur Kahlon, Vasu Bansal, Ramit Mahajan, Varun Mehta, Dharmatma Singh, Ramandeep Kaur, Namita Bansal, Vandana Midha, Ajit Sood; Received March 23, 2022 Accepted June 29, 2022; DOI: https://doi.org/10.5217/ir.2022.00037 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Ahead-of Print